| Literature DB >> 29141563 |
Didem Sohretoglu1,2, Shile Huang2,3.
Abstract
The mushroom Ganoderma lucidum (G. lucidum) has been used for centuries in Asian countries to treat various diseases and to promote health and longevity. Clinical studies have shown beneficial effects of G. lucidum as an alternative adjuvant therapy in cancer patients without obvious toxicity. G. lucidum polysaccharides (GLP) is the main bioactive component in the water soluble extracts of this mushroom. Evidence from in vitro and in vivo studies has demonstrated that GLP possesses potential anticancer activity through immunomodulatory, anti-proliferative, pro-apoptotic, anti-metastatic and anti-angiogenic effects. Here, we briefly summarize these anticancer effects of GLP and the underlying mechanisms. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.Entities:
Keywords: Ganoderma lucidum polysaccharides; Reishi; anti-angiogenic; anti-cancer; anti-metastatic; anti-proliferative; immunomodulatory; pro-apoptotic.
Mesh:
Substances:
Year: 2018 PMID: 29141563 PMCID: PMC6624854 DOI: 10.2174/1871520617666171113121246
Source DB: PubMed Journal: Anticancer Agents Med Chem ISSN: 1871-5206 Impact factor: 2.505